Medtronic (Medtronic) Interest Expense

: $-703 Mil (TTM As of Jan. 2024)

View and export this data going back to 1980. Start your Free Trial

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Medtronic's interest expense for the three months ended in Jan. 2024 was $ -188 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jan. 2024 was $-703 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Medtronic's Operating Income for the three months ended in Jan. 2024 was $ 1,503 Mil. Medtronic's Interest Expense for the three months ended in Jan. 2024 was $ -188 Mil. Medtronic's Interest Coverage for the quarter that ended in Jan. 2024 was 7.99. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medtronic Interest Expense Historical Data

The historical data trend for Medtronic's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medtronic Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Interest Expense

-1,444.00

-1,092.00

-925.00

-553.00

-636.00

Medtronic Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Interest Expense																-167.00	-187.00	-148.00	-180.00	-188.00

Medtronic Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-703 Mil.

Medtronic (NYSE:MDT) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medtronic's Interest Expense for the three months ended in Jan. 2024 was $-188 Mil. Its Operating Income for the three months ended in Jan. 2024 was $1,503 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jan. 2024 was $24,153 Mil.

Medtronic's Interest Coverage for the quarter that ended in Jan. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Jan. 2024 )	/	Interest Expense (Q: Jan. 2024 )
	=	-1	*	1503	/	-188
	=	7.99

The higher the ratio, the stronger the company's financial strength is.

Medtronic (Medtronic) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medtronic PLC (NYSE:MDT) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

MDTN:Mexico 1MDT:Italy 2M6:Germany 2M6:Germany 2M6:Germany 2M6:Germany MDTC34:Brazil MDT:Austria MDT:Argentina

Address

Lower Hatch Street, 20 On Hatch, Dublin, IRL, 2

Website

https://www.medtronic.com

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.

Executives

Brett A. Wall	officer: EVP & Group Pres Restora Thera	710 MEDTRONIC PARKWAY, LC300, MINNEAPOLIS MN 55432
Gregory L Smith	officer: EVP Global Ops & Supply Chain	710 MEDTRONIC PARKWAY, LC300, MINNEAPOLIS MN 55432
Michael Marinaro	officer: EVP & President, Surgical OU	710 MEDTRONIC PARKWAY NE, LC300, MINNEAPOLIS MN 55432
Hoedt Rob Ten	officer: EVP & President EMEAC	710 MEDTRONIC PKWY, MSLC300, MINNEAPOLIS MN 55432
Gregory P Lewis	director	C/O HONEYWELL INTERNATIONAL INC., 300 SOUTH TRYON STREET, CHARLOTTE NC 28202
Sean Salmon	officer: EVP & Group President Diabetes	MEDTRONIC PLC, 710 MEDTRONIC PARKWAY, LC300, MINNEAPOLIS MN 55432
Lidia Fonseca	director	358 SOUTH MAIN STREET, BURLINGTON NC 27215
Karen L Parkhill	officer: EVP & Chief Financial Officer	1717 MAIN STREET, MC 6402, DALLAS TX 75201
Ivan K Fong	officer: EVP GENERAL COUNSEL & SECR	3M CENTER, ST. PAUL MN 55144-1000
Robert John White	officer: EVP & President MITG	MEDTRONIC PLC, 710 MEDTRONIC PKWY MS LC300, MINNEAPOLIS MN 55432
Richard H Anderson	director	MEDTRONIC, INC, 710 MEDTRONIC PKWY, MS LC310, MINNEAPOLIS MN 55432-5604
Bradley E Lerman	officer: SVP General Counsel & Corp Sec	MEDTRONIC, INC., 710 MEDTRONIC PKWY MSLC300, MINNEAPOLIS MN 55432
Geoffrey Martha	officer: Sr VP, Strategy & Bus Dev	710 MEDTRONIC PKWAY, MS LC300, MINNEAPOLIS MN 55432
Jennifer M Kirk	officer: Chief Accounting Officer	5 GREENWAY PLAZA, SUITE 110, HOUSTON TX 77046
John R Liddicoat	officer: EVP & President of Americas	MEDTRONIC PLC, 710 MEDTRONIC PKWY, MS LC300, MINNEAPOLIS MN 55432